Baptist Health Doc-to-Doc

Colchicine Unveiled: A New Dawn in Cardiovascular Prevention

Baptist Health

Join Baptist Health Miami Cardiac & Vascular Institute experts Jonathan Fialkow, M.D., FACC, Adedapo (Dapo) Iluyomade, M.D., and Sergiu Darabant, M.D. as they discuss how this development could revolutionize the approach to combating cardiometabolic diseases through targeting inflammation, and what it means for your patients.

 In this enlightening episode, we delve into the groundbreaking FDA approval of colchicine for the prevention of major adverse cardiovascular events. Join us as we explore the journey of this ancient remedy, traditionally used for gout, now emerging as a promising agent in cardioprotection. We dissect the pivotal clinical trials and evidence-based data that led to this landmark decision, shedding light on colchicine's mechanism of action and its potential role in reshaping preventive cardiology. 

 

Guests:

 

Jonathan Fialkow, M.D., FACC                          

Chief Medical Executive for Population Health, Value and Primary Care 

Deputy Director of Miami Cardiac & Vascular Institute

Chief of Cardiology, Baptist Hospital

 

Adedapo (Dapo) Iluyomade, M.D., Preventive Cardiologist, Baptist Health Miami Cardiac & Vascular Institute

 

Sergiu Darabant, M.D., Cardiologist, Baptist Health Miami Cardiac & Vascular Institute